+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Precision Medicine Software Market by Delivery Mode (On-Premise & Cloud-Based), End User (Healthcare Providers, Research Centers & Government Institutes, Pharmaceutical & Biotechnology Companies), Application, and Region - Global Forecast to 2024

  • ID: 4757890
  • Report
  • Region: Global
  • 115 Pages
  • Markets and Markets
1 of 6
The Precision Medicine Software Market is Projected to Grow at a CAGR of 11.5% During the Forecast Period

FEATURED COMPANIES

  • 2bprecise, LLC
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Gene42, Inc.
  • Human Longevity, Inc.
  • Lifeomic Health, LLC
  • MORE

“The precision medicine software market is projected to grow at a CAGR of 11.5% during the forecast period.”

The precision medicine software market is projected to reach USD 2.0 billion by 2024 from USD 1.2 billion in 2019, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & and VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. However, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and a dearth lack of skilled IT professionals in healthcare are expected to restrain market growth to a certain extent in the coming years.

“The cloud-based delivery mode segment is expected to grow at the highest rate during the forecast period.”

On the basis of delivery mode, the back-end revenue cycle management market is segmented into on-premise and cloud-based modes. The cloud-based delivery mode segment is estimated to witness the highest CAGR during the forecast period. Cloud-based solutions help healthcare organizations share and integrate information from different locations, and these solutions are less expensive less costly to install and maintain than on-premise solutions, which contribute to the high growth and popularity of the cloud-based delivery model.

“The health providers segment is expected to hold the largest market share during the forecast period.”

On the basis of end user, the precision medicine software market has been segmented into healthcare providers, research centers & government institutes, pharmaceutical & biotechnology companies, and other end users. The healthcare providers segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the growing availability of precision medicine software and a rising emphasis on providing personalized medicine in hospitals.

“Growing investments and favorable initiatives for the implementation of precision medicine software in North America the North American region is expected to offer growth opportunities in this region.”

Geographically, the precision medicine software market is segmented into North America, Europe, Asia, and the Rest of the World. The North American market is expected to grow at the highest rate during the forecast period. Growth in this region can be attributed to growing investments and favorable initiatives for the implementation of precision medicine software. Several major global players are based in the US, owing to which the US has become a center for innovation in the precision medicine software market.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 55%, Tier 2: 20%, and Tier 3: 25%
  • By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
  • By Region: North America: 20%, Europe: 25%, APAC: 40%, and RoW: 15%

The major players in the market include Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands).

Research Coverage
This report studies the precision medicine software market based on delivery mode, end user, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis - industry trends, the market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the precision medicine software market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 2bprecise, LLC
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Gene42, Inc.
  • Human Longevity, Inc.
  • Lifeomic Health, LLC
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Precision Medicine Software: Market Overview
4.2 Geographic Analysis: North American Precision Medicine Software Market, By Delivery Mode
4.3 Us Precision Medicine Software Market
4.4 Geographical Snapshot of the Precision Medicine Software Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Government Funding in Precision Medicine Initiatives
5.2.1.2 Partnerships Among Pharmaceutical and Software Companies
5.2.1.3 Entry of New Players and Vc Funding
5.2.1.4 Growth in the Number of Cancer Patients
5.2.2 Restraints
5.2.2.1 High Cost of Deployment
5.2.3 Opportunities
5.2.3.1 Emerging Countries
5.2.3.2 Cloud-Based Solutions
5.2.3.3 Artificial Intelligence in Precision Medicine
5.2.4 Challenges
5.2.4.1 Secure Storage of Large Volumes of Sequenced Data
5.2.4.2 Lack of Reimbursement for Precision Medicine-Based Treatments
5.2.4.3 Lack of Skilled It Professionals in Healthcare

6 Precision Medicine Software Market, By Delivery Mode
6.1 Introduction
6.2 On-Premise Delivery Mode
6.2.1 Benefits Offered By the On-Premise Delivery Model and Limited Penetration of Cloud-Based Technologies to Drive Market Growth
6.3 Cloud-Based Delivery Mode
6.3.1 Open-Access Nature of Cloud-Based Models Poses Security Challenges

7 Precision Medicine Software Market, By End User
7.1 Introduction
7.2 Healthcare Providers
7.2.1 Precision Medicine is Used By Healthcare Providers to Determine Disease Susceptibility and Provide Personalized Treatments
7.3 Research Centers and Government Institutes
7.3.1 Increasing Funding for Research Will Drive the Usage and Adoption of Precision Medicine Software in This Segment
7.4 Pharmaceutical & Biotechnology Companies
7.4.1 Increasing Emphasis on Pharmacogenomics Due to Its Applications in Drug Development is to Drive Market Growth
7.5 Other End Users

8 Precision Medicine Software Market, By Application
8.1 Introduction
8.2 Oncology
8.2.1 Oncology Segment to Witness the Highest Growth in the Precision Medicine Software Market
8.3 Pharmacogenomics
8.3.1 Pharmacogenomics is A Potential Solution to Reduce Healthcare Costs Associated With Ades and Poor Response to Pharmacotherapy
8.4 Rare Diseases
8.4.1 Increasing Incidence of Rare Diseases to Drive Market Growth
8.5 Other Applications

9 Precision Medicine Software Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Government Funding to Support Market Growth in the US
9.2.2 Canada
9.2.2.1 Rising Incidence of Cancer in Canada Will Drive the Demand for Precision Medicine Software
9.3 Europe
9.3.1 Eu5
9.3.1.1 Favorable Funding Scenario Will Support Market Growth in Eu5
9.3.2 Rest of Europe
9.4 Asia
9.4.1 Growing Research Investments in China, Japan & India Will Contribute to Market Growth in Asia
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking of Players, 2018
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Scenario
10.4.1 Solution Launches
10.4.2 Expansions
10.4.3 Partnerships, Agreements, and Collaborations
10.4.4 Acquisitions

11 Company Profiles
11.1 Syapse, Inc.
11.2 2bprecise, LLC
11.3 Fabric Genomics, Inc.
11.4 Foundation Medicine, Inc.
11.5 Sophia Genetics Sa
11.6 Pieriandx, Inc.
11.7 N-Of-One, Inc. (A Subsidiary of Qiagen N.V.)
11.8 Human Longevity, Inc.
11.9 Translational Software Inc.
11.10 Sunquest Information Systems, Inc.
11.11 Gene42, Inc.
11.12 Lifeomic Health, LLC

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables
Table 1 Government Initiatives in the Field of Precision Medicine Software
Table 2 Start-Up Companies in the Precision Medicine Software Market
Table 3 Market, By Delivery Mode, 2017–2024 (USD Million)
Table 4 On-Premise Precision Medicine Software Market, By Region, 2017–2024 (USD Million)
Table 5 North America: On-Premise Precision Medicine Software Market, By Country, 2017–2024 (USD Million)
Table 6 Europe: On-Premise Precision Medicine Software Market, By Region, 2017–2024 (USD Million)
Table 7 Cloud-Based Precision Medicine Software Market, By Region, 2017–2024 (USD Million)
Table 8 North America: Cloud-Based Precision Medicine Software Market, By Country, 2017–2024 (USD Million)
Table 9 Europe: Cloud-Based Precision Medicine Software Market, By Region, 2017–2024 (USD Million)
Table 10 Market, By End User, 2017–2024 (USD Million)
Table 11 Market for Healthcare Providers, By Region, 2017–2024 (USD Million)
Table 12 North America: Market for Healthcare Providers, By Country, 2017–2024 (USD Million)
Table 13 Europe: Market for Healthcare Providers, By Country, 2017–2024 (USD Million)
Table 14 Market for Research Centers and Government Institutes, By Region, 2017–2024 (USD Million)
Table 15 North America: Market for Research Centers and Government Institutes, By Country, 2017–2024 (USD Million)
Table 16 Europe: Market for Research Centers and Government Institutes, By Country, 2017–2024 (USD Million)
Table 17 Market for Pharmaceutical and Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 18 North America: Market for Pharmaceutical and Biotechnology Companies, By Country, 2017–2024 (USD Million)
Table 19 Europe: Market for Pharmaceutical and Biotechnology Companies, By Country, 2017–2024 (USD Million)
Table 20 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 21 North America: Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 22 Europe: Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 23 Market, By Application, 2017–2024 (USD Million)
Table 24 Market for Oncology, By Region, 2017–2024 (USD Million)
Table 25 North America: Market for Oncology, By Country, 2017–2024 (USD Million)
Table 26 Europe: Market for Oncology, By Region, 2017–2024 (USD Million)
Table 27 Market for Pharmacogenomics, By Region, 2017–2024 (USD Million)
Table 28 North America: Market for Pharmacogenomics, By Country, 2017–2024 (USD Million)
Table 29 Europe: Market for Pharmacogenomics, By Region, 2017–2024 (USD Million)
Table 30 Market for Rare Diseases, By Region, 2017–2024 (USD Million)
Table 31 North America: Market for Rare Diseases, By Country, 2017–2024 (USD Million)
Table 32 Europe: Market for Rare Diseases, By Region, 2017–2024 (USD Million)
Table 33 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 34 North America: Market for Other Applications, By Country, 2017–2024 (USD Million)
Table 35 Europe: Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 36 Market, By Region, 2017–2024 (USD Million)
Table 37 North America: Market, By Country, 2017–2024 (USD Million)
Table 38 North America: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 39 North America: Market, By End User, 2017–2024 (USD Million)
Table 40 North America: Market, By Application, 2017–2024 (USD Million)
Table 41 US: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 42 US: Market, By End User, 2017–2024 (USD Million)
Table 43 US: Market, By Application, 2017–2024 (USD Million)
Table 44 Canada: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 45 Canada: Market, By End User, 2017–2024 (USD Million)
Table 46 Canada: Market, By Application, 2017–2024 (USD Million)
Table 47 Europe: Market, By Region, 2017–2024 (USD Million)
Table 48 Europe: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 49 Europe: Market, By End User, 2017–2024 (USD Million)
Table 50 Europe: Market, By Application, 2017–2024 (USD Million)
Table 51 Eu5: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 52 Eu5: Market, By End User, 2017–2024 (USD Million)
Table 53 Eu5: Market, By Application, 2017–2024 (USD Million)
Table 54 ROE: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 55 ROE: Market, By End User, 2017–2024 (USD Million)
Table 56 ROE: Market, By Application, 2017–2024 (USD Million)
Table 57 Asia: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 58 Asia: Market, By End User, 2017–2024 (USD Million)
Table 59 Asia: Market, By Application, 2017–2024 (USD Million)
Table 60 RoW: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 61 RoW: Market, By End User, 2017–2024 (USD Million)
Table 62 RoW: Market, By Application, 2017–2024 (USD Million)
Table 63 Solution Launches
Table 64 Expansions
Table 65 Partnerships, Agreements, and Collaborations
Table 66 Acquisitions

List of Figures
Figure 1 Research Methodology: Precision Medicine Software
Figure 2 Research Design
Figure 3 Sampling Frame: Primary Research
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market Share, By Delivery Mode, 2018
Figure 8 Market Share, By End User, 2018
Figure 9 Market Share, By Application, 2018
Figure 10 Geographic Snapshot of the Precision Medicine Software Market
Figure 11 Rising Government Funding in Precision Medicine Initiatives to Drive Market Growth During the Forecast Period
Figure 12 On-Premise Delivery Mode Accounted for the Largest Share of the North American Precision Medicine Software Market in 2018
Figure 13 Healthcare Providers Accounted for the Largest Market Share in 2018
Figure 14 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Market, By Region, 2019 vs. 2024 (USD Million)
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia: Market Snapshot
Figure 20 RoW: Market Snapshot
Figure 21 Key Developments in the Precision Medicine Software Market Between 2016 and 2019
Figure 22 Market Ranking, By Key Player (2018)
Figure 23 Market (Global), Competitive Leadership Mapping, 2018

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • 2bprecise, LLC
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Gene42, Inc.
  • Human Longevity, Inc.
  • Lifeomic Health, LLC
  • N-Of-One, Inc. (A Subsidiary of Qiagen N.V.)
  • Pieriandx, Inc.
  • Sophia Genetics Sa
  • Sunquest Information Systems, Inc.
  • Syapse, Inc.
  • Translational Software Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4757890
Adroll
adroll